Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    "Cutaneous sclerosis"
Show Display Options
Rank Status Study
1 Completed
Has Results
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
Conditions: Graft Versus Host Disease;   Systemic Scleroderma
Interventions: Drug: imatinib mesylate;   Biological: rituximab
2 Completed Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
Conditions: Graft vs Host Disease;   Cutaneous Sclerosis;   Bronchiolitis Obliterans

Study has passed its completion date and status has not been verified in more than two years.